Escalas en Neurología - Sociedade Galega de Neuroloxia

11-ESCALAS (183-224) 3/6/08 11:40 Página 224
J.A. MOLINA, J. GONZÁLEZ DE LA ALEJA, F. BERMEJO PAREJA, P. MARTÍNEZ-MARTÍN
Stebbins, G. T., y Goetz, C. G. 1998, «Factor structure of the Unified Parkinson‘s Disease Rating
Scale: Motor examination section», Mov Disord,13: 633-636.
Stebbins, G.T., Goetz, C. G., Lang, A. E., y Cubo, E. 1999, «Factor analysis of the motor section
of the Unified Parkinson’s Disease Rating Scale during the off-slate», Mov Disord,
14: 585-589.
Tolosa, E., Blesa, R., Bayés, A., y Forcadell, F. 1987, «Low-dose bromocriptine in the early
phases of Parkinsons disease», Clin Neuropharmacol, 10: 168-174.
Van Hilten, J. J., van der Zwan, A. D., Zwinderman, A. H., y Roos, R. A. 1994, «Rating impairment
and disability in Parkinson’s disease: Evaluation of the Unified Parkinsons Disease
Rating Scale», Mov Disord, 9: 84-88.
Wade, D.T. 1998, Measurement in neurological rehabilitation, Oxford University Press, New
York.
Webster, D. D. 1968, «Critical analysis of disability in Parkinson ‘s disease», Mod Treat, 5:
257-282.
Yahr, M. D., Duvoisin, R. C., Schear, M. J. et al. 1969, «Treatment in Parkinsonism with l-dopa»,
Arch Neurol, 21: 343-354.
� 224 �